PlainPill

Lithium

The short answer. People are split on Lithium — 54% of 24 say it helped. It is most often used for mood: 76% of 17 reports say that improved. It is well studied — 581 meta-analyses on PubMed.

What users report
54%helped24 reports · medium confidence
13 helped4 mixed7 didn't help

From 69 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
581
meta-analyses
979
RCTs
80,836
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Lithium does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 581 meta-analyses on PubMed ↗ · 979 randomized trials ↗

Ageing Res Rev · 2024 · Meta-analysis / systematic review
Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis

Conclusion: Although it is yet to be determined which is more effective between lithium or lecanemab or donanemab, lithium may be more effective than aducanumab. Aducanumab, lecanemab and donanemab do not appear to differ in their effectiveness on cognitive function. Low-dose lithium may be safer than aducanumab, lecanemab and donanemab.

PubMed 38253184 ↗
Acta Psychiatr Scand · 2025 · Meta-analysis / systematic review
Treatment of Early-Onset Specified and Unspecified Bipolar Disorders: A Systematic Review and Strategies for Identifying and Managing a Thermally Dysregulated Subtype in Children

Conclusion: Good support was provided in the 11 studies for the use of adjunctive family-focused psychotherapeutic approaches, and this approach should be considered an important part of any treatment regimen. The pharmacological treatment landscape for S-USBD lacks a systematic research base, warranting further exploration with controlled clinical trials. Case series indicate promising treatment outcomes for TSDD with high-dose lithium, clonidine, ketamine, and other cooling measures. Validation of this novel treatment strategy in controlled trials is needed to advance the management of the S-USBD varian

PubMed 40844121 ↗
J Esthet Restor Dent · 2025 · Meta-analysis / systematic review
Survival and Complication Rates of Feldspathic, Leucite-Reinforced, Lithium Disilicate and Zirconia Ceramic Laminate Veneers: A Systematic Review and Meta-Analysis

Conclusion: Feldspathic, LRGC and LDS laminate-veneers showed high survival-rates at long-term observation. LDS slightly outperforms feldspathic and LRGC laminate-veneers with lower long-term complication rates. More studies providing long-term data on zirconia laminate-veneers are needed.

PubMed 39523553 ↗
Lancet Psychiatry · 2024 · Meta-analysis / systematic review
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis

Conclusion: Considering non-specific effects, as evidenced in placebo groups, the incidence of antidepressant discontinuation symptoms is approximately 15%, affecting one in six to seven patients who discontinue their medication. Subgroup analyses and heterogeneity figures point to factors not accounted for by diagnosis, medication, or trial-related characteristics, and might indicate subjective factors on the part of investigators, patients, or both. Residual or re-emerging psychopathology needs to be considered when interpreting the results, but our findings can inform clinicians and patients about the

PubMed 38851198 ↗
Registered clinical trials

459 human trials on ClinicalTrials.gov test Lithium — 247 completed, 34 recruiting now. See all on ClinicalTrials.gov ↗

Reports to the FDA

Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.

9 reports name a product containing Lithium (2010–2025); 4 involved hospitalization or worse. Most often reported:

  • Mania · 1
  • Abdominal pain upper · 1
  • Vertigo · 1
  • Feeling abnormal · 1
  • Nausea · 1
  • Fatigue · 1

A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

Boxed warning (the FDA's strongest label warning): “LITHIUM TOXICITY Lithium toxicity is closely related to serum lithium concentrations, and can occur at doses close to therapeutic concentrations. Facilities for prompt and accurate serum lithium determinations should be available before initiating treatment. WARNING: LITHIUM TOXICITY Lithium…”

Full label on DailyMed (NIH) ↗

Reports to the FDA about the drug (FAERS)

41,698 adverse-event reports mention Lithium. Most often reported:

  • Toxicity to various agents · 3,426
  • Drug ineffective · 3,368
  • Tremor · 2,583
  • Drug interaction · 2,575
  • Nausea · 2,219
  • Off label use · 2,161

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Lithium E — an unlikely cause of liver injury. LiverTox entry ↗

Plain-language guides from the US government: MedlinePlus: Lithium ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

sickness ×1brain fog ×1tremors ×1rls ×1neck twitching ×1headache ×1apathy ×1drowsiness ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“my doctor put me on low dose lithium a couple months ago... it has changed my life.”
HelpedRead the discussion ↗
“I'm dumber than ever on lithium... Lithium is either interphering with my Adderall or the cognitive dampening is cancelling out the focus and alertness benefits.”
Didn't helpRead the discussion ↗
“Lithium was the only supplement that I took that produced almost the exact depressive results you describe with AlphaGPC.”
Didn't helpRead the discussion ↗
“I personally used 2 - 5mg elemental lithium about twice a week ... improvement in cognitive and mood stabilization.”
HelpedRead the discussion ↗
Read more Lithium reviews →
Top discussions (5)

Lithium compared

Other options for mood

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate